Results 81 to 90 of about 2,997,094 (204)

Vulvar Neoplasia Associated with Other Primary Malignancies

open access: yes, 2009
It is recognized that a significant number of patients with vulvar neoplasia have had previous, concurrent, or subsequent genital tract neoplasia. This has resulted in speculation that there may be a common etiology and, in particular, of the possibility
趙光漢;張道遠;陳瑞堅;林鶴雄;周松男;林惠美;黃麗秋;黃思誠   +1 more
core  

Reconstructive Surgery versus Primary Closure following Vulvar Cancer Excision: A Wide Single-Center Experience

open access: yes, 2022
(1) Background: plastic reconstruction in vulvar surgery can lead to a better treatment outcome than primary closure. This study aims to compare the preoperative parameters (co-morbidities and tumor size) and postoperative results (tumor free margins and
Andrea Miranda   +7 more
core   +1 more source

Vulvar cancer incidence and net survival in Sweden 1960 to 2019: A population‐based national study

open access: yesActa Obstetricia et Gynecologica Scandinavica
Introduction Vulvar cancer is a rare gynecological cancer affecting mostly older women. The aim of this population‐based study was to investigate the incidence and net survival of vulvar cancer in Swedish women from 1960 to 2019.
Louise Moberg   +4 more
doaj   +1 more source

Induction chemotherapy with cemiplimab in a patient with coexistent vulvar cancer and autoimmune disease: A case report

open access: yesGynecologic Oncology Reports
There is limited data regarding the use of immunotherapy for patients with vulvar squamous cell carcinoma and coexisting autoimmune disease. Cemiplimab is a PD-1 inhibitor approved for use in patients with locally advanced and metastatic cutaneous ...
Elizabeth G. Thayer   +6 more
doaj   +1 more source

Current Techniques for Detecting Sentinel Lymph Nodes in Vulvar Cancer

open access: yesКреативная хирургия и онкология, 2019
Introduction. Vulvar cancer belongs to the group of rare neoplasms and accounts for about 4% of all gynecological malignant tumours. One of the important barriers to the spread of the tumour cell population is the lymph nodes.
Sh. Kh. Gantsev   +2 more
doaj   +1 more source

HPV42 – a human papillomavirus classified as a low‐risk type with oncogenic potential

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Human papillomavirus (HPV) type 42 is a rare HPV type currently classified as “low‐risk” and belongs to the alpha genus. It has primarily been detected in benign vulvar papillomas and is predominantly associated with benign lesions such as anogenital warts.
Sven Niklas Burmann   +7 more
wiley   +1 more source

The therapeutic process and care problems of a patient with advanced vulvar cancer

open access: yes
The study analysed the case of a 74-year-old woman with a diagnosis of FIGO IVA vulvar carcinoma. The patient was also suffering from other diseases such as type 2 diabetes, hypertension, obesity, and permanent atrial fibrillation.
Anna W. Szablewska, Amelia J. Sobala
core   +1 more source

Chemoradiation in advanced vulval carcinoma [PDF]

open access: yes, 2008
Includes abstract.Includes bibliographical references (leaves 68-74).Vulval carcinoma is uncommon, affecting approximately 2 per 100 000 women annually. The treatment of choice is radical vulvectomy and inguinal lymph node dissection.
Rogers, Linda Joy
core   +1 more source

Vulvar Cancers and Precancerous Lesions - Surgical Management with Reconstructive Strategies: A Case Series of 4 Patients

open access: yesAnnals of Medicine and Medical Sciences
Vulvar cancer constitutes 5% of the malignancies of the female genital tract and 95% of the vulvar cancers are squamous cell carcinoma, followed by melanoma, sarcoma and basalioma.
Dr Nagendra Parvataneni   +6 more
doaj  

Economic Burden of Overweight and Obesity in Sweden: Current Estimates and Future Projections

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Overweight and obesity are major public health challenges and well‐established risk factors for cardiovascular disease, cancer and premature mortality. We estimated the economic burden of overweight and obesity in Sweden in 2023 and projected the future economic burden in 2040 under alternative scenarios of increasing prevalence ...
Adam Fridhammar   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy